194 related articles for article (PubMed ID: 7002102)
1. Antihypertensive action of captopril in angiotensin-salt hypertension.
Muirhead EE; Brooks B; Brosius WL
Arch Pathol Lab Med; 1980 Dec; 104(12):631-4. PubMed ID: 7002102
[TBL] [Abstract][Full Text] [Related]
2. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H
Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314
[TBL] [Abstract][Full Text] [Related]
3. Effects of captopril on the development of tolerance to guanethidine.
Rankin GO; Haas GJ
Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227
[TBL] [Abstract][Full Text] [Related]
4. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
5. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension.
Pörsti I; Säynävälammi P; Arvola P; Nurmi AK; Manninen V; Ylitalo P; Vapaatalo H
Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):543-6. PubMed ID: 3022083
[TBL] [Abstract][Full Text] [Related]
6. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
7. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
Luft FC; Aronoff GR; Evan AP; Connors BA; Weinberger MH; Kleit SA
J Pharmacol Exp Ther; 1982 Feb; 220(2):433-9. PubMed ID: 6276536
[TBL] [Abstract][Full Text] [Related]
8. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system].
Jover B; Dupont M; Casellas D; Mimran A
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235
[TBL] [Abstract][Full Text] [Related]
9. [Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)].
Levenson J; Simon A; Temmar M; Safar M
Nouv Presse Med; 1980 Feb; 9(9):617-9. PubMed ID: 6987622
[TBL] [Abstract][Full Text] [Related]
10. Captopril and salt subtraction to treat "uncontrollable" hypertension in haemodialysis patients.
Wauters JP; Waeber B; Brunner HR; Turini GA; Guignard JP; Gavras H
Proc Eur Dial Transplant Assoc; 1979; 16():610-7. PubMed ID: 232915
[TBL] [Abstract][Full Text] [Related]
11. Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.
Baer L; Radichevich I; Williams GS
J Cardiovasc Pharmacol; 1980; 2 Suppl 2():S206-16. PubMed ID: 6156357
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
Malherbe E; Le Hegarat M; Clostre F; Braquet P
Drugs Exp Clin Res; 1988; 14(2-3):83-8. PubMed ID: 2970955
[TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma renin activity and hypotensive effect of captopril in dogs.
Hamed AT; Lokhandwala MF; Buckley JP; Jandhyala BS
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):195-204. PubMed ID: 6994184
[TBL] [Abstract][Full Text] [Related]
14. Effects of captopril on salt appetite in sodium-replete rats and rats treated with desoxycorticosterone acetate (DOCA).
Evered MD; Robinson MM
J Pharmacol Exp Ther; 1983 May; 225(2):416-21. PubMed ID: 6341542
[TBL] [Abstract][Full Text] [Related]
15. [Captopril - profile of a new antihypertensive (author's transl)].
Gross F
MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
[TBL] [Abstract][Full Text] [Related]
16. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
Waeber B; Brunner HR; Wauters JP; Gavras H
Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
[No Abstract] [Full Text] [Related]
18. Effect of captopril on brain converting enzyme in the spontaneously hypertensive rat.
Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
Clin Exp Pharmacol Physiol; 1984; 11(3):237-44. PubMed ID: 6086193
[TBL] [Abstract][Full Text] [Related]
19. The hypotensive effect of captopril in hypertensive patients is age-related.
Lijnen P; Fagard R; Groeseneken D; M'Buyamba JR; Staessen J; Amery A
Methods Find Exp Clin Pharmacol; 1983 Nov; 5(9):655-60. PubMed ID: 6366404
[TBL] [Abstract][Full Text] [Related]
20. [Induction of blood plasma carboxycathepsin (angiotensin I-converting enzyme) in normo- and hypertensive rats in response to a single administration of captopril].
Kugaevskaia EV; Eliseeva IuE; Pavlikhina LV; Orekhovich VN; Faermark IF
Biull Eksp Biol Med; 1987 Jan; 103(1):48-50. PubMed ID: 3026518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
